Evidence map›Paper›PMID 34067169›Full record

ArticlePharmaceutics2021

Polymer Particles Bearing Recombinant LEL CD81 as Trapping Systems for Hepatitis C Virus.

Dmitry Polyakov, Ekaterina Sinitsyna, Natalia Grudinina, Mariia Antipchik, Rodion Sakhabeev, Viktor Korzhikov-Vlakh, Mikhail Shavlovsky, Evgenia Korzhikova-Vlakh, Tatiana Tennikova

Open access · goldAbstract read
In one paragraph

Article in Pharmaceutics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

Dmitry PolyakovInstitute of Experimental Medicine, Acad. Pavlov Street 12, 197376 St. Petersburg, Russia.ORCID 0000-0002-1095-3484
Ekaterina SinitsynaInstitute of Macromolecular Compounds, Russian Academy of Sciences, Bolshoy pr. 31, 199004 St. Petersburg, Russia.
Natalia GrudininaInstitute of Experimental Medicine, Acad. Pavlov Street 12, 197376 St. Petersburg, Russia.
Mariia AntipchikInstitute of Macromolecular Compounds, Russian Academy of Sciences, Bolshoy pr. 31, 199004 St. Petersburg, Russia.
Rodion SakhabeevInstitute of Experimental Medicine, Acad. Pavlov Street 12, 197376 St. Petersburg, Russia.ORCID 0000-0002-4367-4924
Viktor Korzhikov-VlakhInstitute of Chemistry, Saint-Petersburg State University, Universitetsky pr. 26, 198504 St. Petersburg, Russia.
Mikhail ShavlovskyInstitute of Experimental Medicine, Acad. Pavlov Street 12, 197376 St. Petersburg, Russia.
Evgenia Korzhikova-VlakhInstitute of Macromolecular Compounds, Russian Academy of Sciences, Bolshoy pr. 31, 199004 St. Petersburg, Russia.ORCID 0000-0002-2530-7709
Tatiana TennikovaInstitute of Chemistry, Saint-Petersburg State University, Universitetsky pr. 26, 198504 St. Petersburg, Russia.
Institute of Experimental Medicine · RUSt Petersburg University · RUInstitute of Macromolecular Compounds · RU

Funding

Russian Science Foundation 19-73-00131
6 · The paper itself

Abstract

Hepatitis C is one of the most common social diseases in the world. The improvements in both the early diagnostics of the hepatitis C and the treatment of acute viremia caused by hepatitis C virus are undoubtedly an urgent task. In present work, we offered the micro- and nanotraps for the capturing of HCV. As a capturing moiety, we designed and synthesized in

Indexed as

interaction of LEL CD81 with E2 proteinpoly(lactic acid)-based micro- and nanoparticlesrecombinant CD81-streptavidin fusion proteintrapping system for HCVvirus-mimicking particles

Identifiers

PMID34067169
PMCPMC8151308
OpenAlexW3161975284

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.